Clinical Trials

Thermo Fisher Machine Learning Deal to Boost Clinical Trials

February 8, 2022 - Thermo Fisher Scientific has announced a partnership with a life science artificial intelligence company, Medidata Acorn AI, that aims to enhance clinical trials for pharmaceutical and biotech companies. The collaboration between the PPD clinical research business of Thermo Fisher and Medidata was to develop PPD TrueCast. This enterprise...


More Articles

FDA Funds Health IT Infrastructure for Rare Disease Research

by Fred Donovan

The FDA is providing funding to the Critical Path Institute (C-Path) and the Organization for Rare Disorders (NORD) for a centralized and standardized health IT infrastructure to support rare disease...

Berkeley Gets $47M NIH Grant for Brain Imaging in Alzheimer’s Trial

by Fred Donovan

University of California, Berkeley, has received a five-year, $47 million grant from the National Institutes of Health (NIH) to use brain imaging in the Alzheimer's Association's...

Cincinnati Children’s Tests AI-Based Clinical Trials Screening Tool

by Fred Donovan

Cincinnati Children’s Hospital Medical Center successfully tested the integration of an artificial intelligence (AI)-powered clinical trials screening system into the clinical workflow at a busy...

NSF Grants $1M to Develop Secure Health IT Infrastructure

by Fred Donovan

The National Science Foundation (NSF) has awarded a three-year, nearly $1 million grant to University of Massachusetts and Elizabethtown College researchers to develop a secure health IT infrastructure...

Researchers Test Blockchain for Clinical Trails’ Data Integrity

by Fred Donovan

Researchers at University of California San Francisco (UCSF) have developed a proof-of-concept method for using blockchain to safeguard data integrity of clinical trials. Blockchain creates an...

Big Data Analytics to Have Major Impact on Pharma Next Year

by Fred Donovan

Big data analytics is expected to have the biggest technology impact on the pharmaceutical industry in 2019, according to a survey of pharm professionals by GlobalData. Thirty-eight percent of...